With just 2 doses in 1 month1
Help protect adult patients in your practice from HBV infection

2 doses of HEPLISAV-B protected more adults across 3 pivotal clinical trials vs 3 doses of Engerix-B®1

Higher rates of protection vs Engerix-B in 3 noninferiority trials

Trial results overview Trial results overview

HEPLISAV-B consistently protected more than
90% of patients in each trial1

Engerix-B is a registered trademark of the GSK group of companies.

Study Results — Study Results
HEPLISAV-B Hepatitis B Vaccine (Recombinant), Adjuvantedâ„¢ HEPLISAV-B Hepatitis B Vaccine (Recombinant), Adjuvantedâ„¢

Thank you for your submission. An automated email containing the Enrollment Letter will be sent to you shortly.

Call 1-84-HEPLISAV (1-844-375-4728)
8 AM to 8 PM, ET, Monday through Friday